GeneDx Holdings Corp. (WGS) EBIT

annual EBIT:

-$23.21M+$146.98M(+86.36%)
December 31, 2024

Summary

  • As of today (September 10, 2025), WGS annual earnings before interest & taxes is -$23.21 million, with the most recent change of +$146.98 million (+86.36%) on December 31, 2024.
  • During the last 3 years, WGS annual EBIT has risen by +$219.34 million (+90.43%).
  • WGS annual EBIT is now at all-time high.

Performance

WGS EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWGSincome statement metrics

quarterly EBIT:

$11.38M+$16.82M(+309.11%)
June 30, 2025

Summary

  • As of today (September 10, 2025), WGS quarterly earnings before interest & taxes is $11.38 million, with the most recent change of +$16.82 million (+309.11%) on June 30, 2025.
  • Over the past year, WGS quarterly EBIT has increased by +$39.85 million (+139.97%).
  • WGS quarterly EBIT is now -65.94% below its all-time high of $33.41 million, reached on September 1, 2021.

Performance

WGS quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWGSincome statement metrics

TTM EBIT:

$6.96M+$39.85M(+121.18%)
June 30, 2025

Summary

  • As of today (September 10, 2025), WGS TTM earnings before interest & taxes is $6.96 million, with the most recent change of +$39.85 million (+121.18%) on June 30, 2025.
  • Over the past year, WGS TTM EBIT has increased by +$115.48 million (+106.42%).
  • WGS TTM EBIT is now at all-time high.

Performance

WGS TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWGSincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

WGS EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+86.4%+140.0%+106.4%
3 y3 years+90.4%+108.5%+103.2%
5 y5 years+19.7%+120.3%+112.4%

WGS EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+94.9%at high+108.5%at high+101.7%
5 y5-yearat high+94.9%-65.9%+106.0%at high+101.7%
alltimeall timeat high+94.9%-65.9%+106.0%at high+101.7%

WGS EBIT History

DateAnnualQuarterlyTTM
Jun 2025
-
$11.38M(-309.1%)
$6.96M(-121.2%)
Mar 2025
-
-$5.44M(-161.8%)
-$32.88M(-30.3%)
Dec 2024
-$23.21M(-86.4%)
$8.81M(-213.2%)
-$47.17M(-42.2%)
Sep 2024
-
-$7.78M(-72.7%)
-$81.62M(-24.8%)
Jun 2024
-
-$28.47M(+44.3%)
-$108.52M(-17.6%)
Mar 2024
-
-$19.72M(-23.1%)
-$131.67M(-23.9%)
Dec 2023
-$170.19M(-62.8%)
-$25.64M(-26.1%)
-$173.05M(-34.0%)
Sep 2023
-
-$34.69M(-32.8%)
-$262.14M(-17.6%)
Jun 2023
-
-$51.62M(-15.5%)
-$318.28M(-20.6%)
Mar 2023
-
-$61.10M(-46.7%)
-$400.68M(-3.6%)
Dec 2022
-$457.51M
-$114.74M(+26.3%)
-$415.67M(+22.1%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$90.82M(-32.2%)
-$340.41M(+57.5%)
Jun 2022
-
-$134.03M(+76.1%)
-$216.18M(+69.4%)
Mar 2022
-
-$76.09M(+92.7%)
-$127.59M(-47.4%)
Dec 2021
-$242.56M(+1.5%)
-
-
Dec 2021
-
-$39.48M(-218.1%)
-$242.56M(-26.1%)
Sep 2021
-
$33.41M(-173.5%)
-$328.11M(-21.4%)
Jun 2021
-
-$45.44M(-76.2%)
-$417.50M(+12.2%)
Mar 2021
-
-$191.05M(+52.8%)
-$372.06M(+105.5%)
Dec 2020
-$238.87M(+725.9%)
-$125.03M(+123.4%)
-$181.01M(+223.4%)
Sep 2020
-
-$55.98M
-$55.98M
Dec 2019
-$28.92M
-
-

FAQ

  • What is GeneDx Holdings Corp. annual earnings before interest & taxes?
  • What is the all time high annual EBIT for GeneDx Holdings Corp.?
  • What is GeneDx Holdings Corp. annual EBIT year-on-year change?
  • What is GeneDx Holdings Corp. quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for GeneDx Holdings Corp.?
  • What is GeneDx Holdings Corp. quarterly EBIT year-on-year change?
  • What is GeneDx Holdings Corp. TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for GeneDx Holdings Corp.?
  • What is GeneDx Holdings Corp. TTM EBIT year-on-year change?

What is GeneDx Holdings Corp. annual earnings before interest & taxes?

The current annual EBIT of WGS is -$23.21M

What is the all time high annual EBIT for GeneDx Holdings Corp.?

GeneDx Holdings Corp. all-time high annual earnings before interest & taxes is -$23.21M

What is GeneDx Holdings Corp. annual EBIT year-on-year change?

Over the past year, WGS annual earnings before interest & taxes has changed by +$146.98M (+86.36%)

What is GeneDx Holdings Corp. quarterly earnings before interest & taxes?

The current quarterly EBIT of WGS is $11.38M

What is the all time high quarterly EBIT for GeneDx Holdings Corp.?

GeneDx Holdings Corp. all-time high quarterly earnings before interest & taxes is $33.41M

What is GeneDx Holdings Corp. quarterly EBIT year-on-year change?

Over the past year, WGS quarterly earnings before interest & taxes has changed by +$39.85M (+139.97%)

What is GeneDx Holdings Corp. TTM earnings before interest & taxes?

The current TTM EBIT of WGS is $6.96M

What is the all time high TTM EBIT for GeneDx Holdings Corp.?

GeneDx Holdings Corp. all-time high TTM earnings before interest & taxes is $6.96M

What is GeneDx Holdings Corp. TTM EBIT year-on-year change?

Over the past year, WGS TTM earnings before interest & taxes has changed by +$115.48M (+106.42%)
On this page